Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Unity Biotechnology, Inc. - Common Stock (NQ:UBX)

0.8091 -0.0109 (-1.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 136,043
Open 0.8300
Bid (Size) 0.8000 (1)
Ask (Size) 0.8388 (39)
Prev. Close 0.8200
Today's Range 0.7801 - 0.8500
52wk Range 0.7003 - 3.100
Shares Outstanding 14,601,258
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
UNITY Biotechnology Announces Complete 36-Week Results from the ASPIRE Phase 2b Study of UBX1325 in Diabetic Macular Edema and Provides Corporate Updates
From Unity Biotechnology, Inc.
Via GlobeNewswire
UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting
From Unity Biotechnology, Inc.
Via GlobeNewswire

Performance

YTD
-29.0%
-29.0%
1 Month
-13.9%
-13.9%
3 Month
-59.9%
-59.9%
6 Month
-32.0%
-32.0%
1 Year
-43.0%
-43.0%

More News

Read More
UNITY Biotechnology Announces Publication in NEJM Evidence Highlighting the Potential of Senolytic Therapeutics to Provide Long-Term Improvements in Vision in DME
From Unity Biotechnology, Inc.
Via GlobeNewswire
UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates
From Unity Biotechnology, Inc.
Via GlobeNewswire
The Future of Healthcare: 10 Predictions For The Next Decade
Via MarketMinute
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
What's going on in today's session
Via Chartmill
These stocks are moving in today's session
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Traders are paying attention to the gapping stocks in Monday's session.
Via Chartmill
Crude Oil Gains 1%; US Composite PMI Surges In March
Via Benzinga
Exposures Fossil Fuels
Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls
Via Benzinga
Discover the top movers in Monday's pre-market session.
Via Chartmill
Dow Jumps Over 300 Points; Chicago Fed National Activity Index Rises In February
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema
From Unity Biotechnology, Inc.
Via GlobeNewswire
UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025
From Unity Biotechnology, Inc.
Via GlobeNewswire
UNITY Biotechnology Appoints Industry Leader and Ophthalmology Expert Yehia Hashad, M.D., to the Board of Directors
From Unity Biotechnology, Inc.
Via GlobeNewswire
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
From Unity Biotechnology, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
UNITY Biotechnology Reports Granting of New Employment Inducement Award
From Unity Biotechnology, Inc.
Via GlobeNewswire
UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer
From Unity Biotechnology, Inc.
Via GlobeNewswire
UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates
From Unity Biotechnology, Inc.
Via GlobeNewswire
UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024
From Unity Biotechnology, Inc.
Via GlobeNewswire
UNITY Biotechnology to Participate in Upcoming Investor Conferences
From Unity Biotechnology, Inc.
Via GlobeNewswire
UNITY Biotechnology, Inc. Reports Second Quarter 2024 Financial Results and Business Updates
From Unity Biotechnology, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Unity Biotechnology, Inc. - Common Stock publicly traded?
Yes, Unity Biotechnology, Inc. - Common Stock is publicly traded.
What exchange does Unity Biotechnology, Inc. - Common Stock trade on?
Unity Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Unity Biotechnology, Inc. - Common Stock?
The ticker symbol for Unity Biotechnology, Inc. - Common Stock is UBX on the Nasdaq Stock Market
What is the current price of Unity Biotechnology, Inc. - Common Stock?
The current price of Unity Biotechnology, Inc. - Common Stock is 0.8091
When was Unity Biotechnology, Inc. - Common Stock last traded?
The last trade of Unity Biotechnology, Inc. - Common Stock was at 05/19/25 04:00 PM ET
What is the market capitalization of Unity Biotechnology, Inc. - Common Stock?
The market capitalization of Unity Biotechnology, Inc. - Common Stock is 11.81M
How many shares of Unity Biotechnology, Inc. - Common Stock are outstanding?
Unity Biotechnology, Inc. - Common Stock has 12M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS